Stay updated on Cabozantinib for PN in NF1: Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for PN in NF1: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T02:20:39.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-27T02:25:36.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study page still displays a 403 Forbidden error. The site footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-20T05:00:46.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T07:47:48.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, preventing access to the study record content.
    Difference
    21%
    Check dated 2026-09-29T02:19:12.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new revision tag (v3.6.6) appears on the page. This indicates a minor update to the page’s version, while the study details themselves appear unchanged.
    Difference
    0.0%
    Check dated 2026-08-31T23:26:19.000Z thumbnail image

Stay in the know with updates to Cabozantinib for PN in NF1: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.